Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Nov 07, 2024 6:05pm
64 Views
Post# 36302083

RE:RE:1 year on

RE:RE:1 year onGood on you Peladawn... That must have been very satisfying being in early... Back in 2004 when I first stumbled across ONCY and Brad Thomson's claims that approval was right around the corner, I too thought I was getting in on Google..in hindsight, I'd now be sitting on millions had I invested in Google, MS and Meta instead... oh well...

I was posting about what I bought as I bought them...  BYON also, paid $14 and doubled my money on that one, it's now around $6....  anyway, the point is ONCY has gone nowhere, besides the little spurt from 0.85 to 1.50 or so recently... it's still significantly down year on year... decade on decade...

The final mBC data has been presented... what else does ONCY need for a partner... meanwhile they aimlessly burn through cash keeping the lights on...

Sure I keep coming back here, it's been a 20 year hobby..!!! There was always the possibility that something might change... but Matt going awol when the results of the End of Phase II meeting results were due, was what smelt bad.

It really doesn't matter what you believe... you've sat on this loser, and I tripled my money by not doing so.

If you're too blind to see that this is likely to be delayed to the point the patents expire, then, you eat yer heart out fella... me... I'm doing just great now... if it drops back below a dollar, I might even wager some of those profits on the next pump... LOL 
<< Previous
Bullboard Posts
Next >>